MYRIAN
ABURTO BARRENECHEA
PROFESORADO ASOCIADO
Imperial College London
Londres, Reino UnidoPublications en collaboration avec des chercheurs de Imperial College London (2)
2020
-
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
The Lancet Respiratory Medicine, Vol. 8, Núm. 5, pp. 453-460
2019
-
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
The Lancet Respiratory Medicine, Vol. 7, Núm. 9, pp. 771-779